 Home > Active Ingredient News > Antitumor Therapy > FDA Eligibility Criteria for Cancer Clinical Trials: Available Therapies in Nontherapeutic Settings (Draft)

FDA Eligibility Criteria for Cancer Clinical Trials: Available Therapies in Nontherapeutic Settings (Draft)

 Last Update: 2022-04-23
 Source: Internet
 Author: User

Tags

dayquil generic name

download messenger

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Guideline Name: FDA Eligibility Criteria for Cancer Clinical Trials: Available Therapies in Nontherapeutic Settings (Draft)

Guide name:

English title: Cancer Clinical Trial Eligibility Criteria: Available Therapy in Non-Curative Settings

English title:

Issuing agency: U.

release date:

brief introduction:

This guidance provides recommendations for clinical investigators and sponsors regarding the inclusion of patients who have not received available treatments for their cancer (often referred to as existing treatment options) into clinical trials of non-curative cancer treatments and biologics

Source: FDA

source:

Download address: Meisi Medical APP
Tips: 78% of users have downloaded the Meisi Medical APP , which is more convenient to read and communicate, please scan the QR code to directly download the APP Meisi Medical APP

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Bulk Peptides Kisspeptin 10 (human) /Kisspeptin 10/ Kisspeptin-10 Acetate CAS 374675-21-5

CAS No.: 374675-21-5

Pharmacy Grade

$10-13/UNIT FOB

Cediranib

CAS No.: 288383-20-0

$22/KG EXW

Upadacitinib hemihydrate API

CAS No.: 2050057-56-0

Pharmacy Grade

$35-45/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.